Natco Pharma Ltd.
791.85+6.7 (+0.85%)
23 Oct, 12:00 AM
Stock News
Natco Pharma Ltd. latest news covering earnings updates, regulatory announcements, analyst actions and market-moving events.
Economic Times
NATCO Pharma subsidiary launches Carboplatin in US market to address shortages
NATCO Pharma Limited launched Carboplatin Injection, a generic version of Paraplatin, in the US through NATCO Pharma USA in manufacturing collaboration with Teyro Labs Pvt Ltd to address a critical shortage, targeting a US market with estimated sales of $27.8 million for the 12 months ending June 2026.
19th Oct '26 9:29 am
Read full article on economictimes.indiatimes.com